Abstract

Cancer prognosis before and after treatment is key for patient management and decision making. Handcrafted imaging biomarkers-radiomics-have shown potential in predicting prognosis. However, given the recent progress in deep learning, it is timely and relevant to pose the question: could deep learning based 3D imaging features be used as imaging biomarkers and outperform radiomics? Effectiveness, reproducibility in test/retest, across modalities, and correlation of deep features with clinical features such as tumor volume and TNM staging were tested in this study. Radiomics was introduced as the reference image biomarker. For deep feature extraction, we transformed the CT scans into videos, and we adopted the pre-trained Inflated 3D ConvNet (I3D) video classification network as the architecture. We used four datasets-LUNG 1 (n=422), LUNG 4 (n=106), OPC (n=605), and H&N 1 (n=89)-with 1270 samples from different centers and cancer types-lung and head and neck cancer-to test deep features' predictiveness and two additional datasets to assess the reproducibility of deep features. Support Vector Machine-Recursive Feature Elimination (SVM-RFE) selected top 100 deep features achieved a concordance index (CI) of 0.67 in survival prediction in LUNG 1, 0.87 in LUNG 4, 0.76 in OPC, and 0.87 in H&N 1, while SVM-RFE selected top 100 radiomics achieved CIs of 0.64, 0.77, 0.73, and 0.74, respectively, all statistically significant differences (p<0.01, Wilcoxon's test). Most selected deep features are not correlated with tumor volume and TNM staging. However, full radiomics features show higher reproducibility than full deep features in a test/retest setting (0.89 vs. 0.62, concordance correlation coefficient). The results show that deep features can outperform radiomics while providing different views for tumor prognosis compared to tumor volume and TNM staging. However, deep features suffer from lower reproducibility than radiomic features and lack the interpretability of the latter.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call